Metabolic outcomes of type 2 diabetes patients with different diabetic durations under the standardized metabolic disease management model

被引：0
|
作者：
杨嘉颖 [1 ]
机构：
[1] Dept Endocrinol Metab,Shanghai General Hosp,Shanghai Jiaotong Univ
来源：
ChinaMedicalAbstracts(InternalMedicine) | 2021年 / 38卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R587.1 [糖尿病];
学科分类号：
1002 ; 100201 ;
摘要：
Objective To explore the metabolic outcomes of type 2 diabetes patients with different durations after 1 year treatment under the standardized metabolic disease management model.Methods( 1) From September 2017 to September 2018,345 type 2 diabetes patients in the Standardized Metabolic Management Center( MMC) of Shanghai General Hospital were recruited and included in this research.
引用
收藏
页码：154 / 155
页数：2
相关论文
共 50 条
  • [41] Metabolic and hemodynamic effects of moxonidine in the Zucker diabetic fatty rat model of type 2 diabetes
    Yakubu-Madus, FE
    Johnson, WT
    Zimmerman, KM
    Dananberg, J
    Steinberg, MI
    DIABETES, 1999, 48 (05) : 1093 - 1100
  • [42] The prevalence of the metabolic syndrome in relation to metabolic control in Albanian type 2 diabetic patients
    Toti, F.
    Nelaj, E.
    Thengjilli, E.
    Vasili, E.
    Bejtja, G.
    Shehu, A.
    DIABETES & METABOLISM, 2011, 37 : A63 - A64
  • [43] THE DAYTIME GLUCOSE PROFILE AS A STANDARDIZED MODEL FOR METABOLIC MANAGEMENT OF DIABETES-MELLITUS IN PREGNANCY
    THURNAU, GR
    PAYNE, GG
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 1991, 34 (01) : 21 - 25
  • [44] Metabolic effects of sitagliptin in patients with type 2 diabetes
    Muscelli, E.
    Casolaro, A.
    Gastaldelli, A.
    Mari, A.
    Seghieri, G.
    Chen, Y.
    Alba, M.
    Holst, J. J.
    Ferrannini, E.
    DIABETOLOGIA, 2011, 54 : S330 - S330
  • [45] The effect of diabetes education and short message service reminders on metabolic control and disease management in patients with type 2 diabetes mellitus
    Guner, Turkan Akyol
    Cosansu, Gulhan
    PRIMARY CARE DIABETES, 2020, 14 (05) : 482 - 487
  • [46] Exenatide and Renal Outcomes in Patients with Type 2 Diabetes and Diabetic Kidney Disease
    Wang, Xiangyu
    Zhang, Huijie
    Zhang, Qian
    Guan, Meiping
    Sheng, Shuyue
    Mo, Wei
    Zou, Mengchen
    Li, Jimin
    Bi, Jianlu
    Tang, Xianyu
    Zeng, Huiyan
    He, Jiali
    Xu, Gugen
    Li, Ping
    Xue, Yaoming
    AMERICAN JOURNAL OF NEPHROLOGY, 2020, 51 (10) : 806 - 814
  • [47] Risk factors in metabolic syndrome predict the progression of diabetic nephropathy in patients with type 2 diabetes
    Chuang, Shih-Ming
    Shih, Hong-Mou
    Chien, Ming-Nan
    Liu, Sun-Chen
    Wang, Chao-Hung
    Lee, Chun-Chuan
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2019, 153 : 6 - 13
  • [48] Diet Treatment Compliance, Metabolic Control and Diabetic Complications in the Chinese Patients with Type 2 Diabetes
    Yang, Xiaoping
    Li, Xiang
    Xu, Zhangrong
    Wang, Yuzhen
    Liu, Yanjun
    DIABETES, 2010, 59 : A601 - A601
  • [49] Effects of diabetes education program on metabolic control among Saudi type 2 diabetic patients
    Al-Shahrani, Abdullah M.
    Hassan, Asim
    Al-Rubeaan, Khalid A.
    Al Sharqawi, Ahmad H.
    Ahmad, Najlaa A.
    PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2012, 28 (05) : 925 - 930
  • [50] New insights into metabolic and vascular management of type 2 diabetes
    Keen, H
    Cerasi, E
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2000, 14 (04) : 179 - 179
12345